CurrentEndo
Get Weekly

CurrentEndo coverage · page 2 of 3

Nature Medicine

Briefs 41–80 of 100 CurrentEndo has covered from this journal, newest publication first

Latest from Nature Medicine

All coverage, newest first

  1. Nat Med

    Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial

    Randomized controlled trialObesity

  2. Nat Med

    An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial

    Randomized controlled trialObesity

  3. Nat Med

    Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial

    Randomized controlled trialT1D

  4. Nat Med

    A microRNA-based dynamic risk score for type 1 diabetes

    Diagnostic or prognostic studyT1D

  5. Nat Med

    Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery

    Research articleObesity

  6. Nat Med

    Microbiome–metabolome dynamics associated with impaired glucose control and responses to lifestyle changes

    Cohort studyT2D & other

  7. Nat Med

    Single-cell profiling of the human endometrium in polycystic ovary syndrome

    Mechanistic studyReproductive endocrine

  8. Nat Med

    Anti-obesity medication for weight loss in early nonresponders to behavioral treatment: a randomized controlled trial

    Randomized controlled trialObesity

  9. Nat Med

    Reduced-energy diet in women with gestational diabetes: the dietary intervention in gestational diabetes DiGest randomized clinical trial

    Randomized controlled trialDiabetes in pregnancy

  10. Nat Med

    Telemedicine-supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trial

    Randomized controlled trialT2D & other

  11. Nat Med

    Long-term liver outcomes after metabolic surgery in compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis

    Cohort studyObesity

  12. Nat Med

    Mapping the effectiveness and risks of GLP-1 receptor agonists

    Cohort studyT2D & other

  13. Nat Med

    Subcutaneous weekly semaglutide with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossover trial

    Randomized controlled trialT1D

  14. Nat Med

    Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trial

    Randomized controlled trialObesity

  15. Nat Med

    Effects of early, late and self-selected time-restricted eating on visceral adipose tissue and cardiometabolic health in participants with overweight or obesity: a randomized controlled trial

    Randomized controlled trialObesity

  16. Nat Med

    Burdens of type 2 diabetes and cardiovascular disease attributable to sugar-sweetened beverages in 184 countries

    Research articleT2D & other

  17. Nat Med

    Proteomic changes upon treatment with semaglutide in individuals with obesity

    Research articleObesity

  18. Nat Med

    Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease

    Diagnostic or prognostic studyLipids & liver

  19. Nat Med

    Genetic basis of early onset and progression of type 2 diabetes in South Asians

    Research articleT2D & other

  20. Nat Med

    Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial

    Secondary analysisObesity

  21. Nat Med

    Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

    Randomized controlled trialObesity

  22. Nat Med

    Subclassification of obesity for precision prediction of cardiometabolic diseases

    Cohort studyObesity

  23. Nat Med

    Lipid profiling identifies modifiable signatures of cardiometabolic risk in children and adolescents with obesity

    Cross-sectional studyObesity

  24. Nat Med

    The burden of diabetes-associated multiple long-term conditions on years of life spent and lost

    Cohort studyT2D & other

  25. Nat Med

    Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial

    Randomized controlled trialT1D

  26. Nat Med

    Integrated image-based deep learning and language models for primary diabetes care

    Cohort studyComplications

  27. Nat Med

    Lipidome changes due to improved dietary fat quality inform cardiometabolic risk reduction and precision nutrition

    Randomized controlled trialT2D & other

  28. Nat Med

    Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial

    Randomized controlled trialReproductive endocrine

  29. Nat Med

    Adaptive selection at G6PD and disparities in diabetes complications

    Research articleComplications

  30. Nat Med

    Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes

    Cohort studyT2D & other

  31. Nat Med

    Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

    Secondary analysisComplications

  32. Nat Med

    Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial

    Randomized controlled trialLipids & liver

  33. Nat Med

    Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

    Secondary analysisObesity

  34. Nat Med

    Effectiveness of bariatric metabolic surgery versus glucagon-like peptide-1 receptor agonists for prevention of congestive heart failure

    Cohort studyObesity

  35. Nat Med

    Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

    Secondary analysisObesity

  36. Nat Med

    Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes

    Cohort studyT1D

  37. Nat Med

    Placental IGFBP1 levels during early pregnancy and the risk of insulin resistance and gestational diabetes

    Mechanistic studyDiabetes in pregnancy

  38. Nat Med

    Continuous glucose monitoring and intrapersonal variability in fasting glucose

    Cohort study

  39. Nat Med

    Maternal diabetes and risk of attention-deficit/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother–child pairs

    Cohort studyDiabetes in pregnancy

  40. Nat Med

    Multi-ancestry polygenic mechanisms of type 2 diabetes

    Meta-analysisT2D & other

All 100 Briefs in ExploreShowing Briefs 41–80 of 100, newest first